These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19151048)

  • 1. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
    Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery.
    Sahu MK; Das A; Malik V; Subramanian A; Singh SP; Hote M
    Ann Card Anaesth; 2016; 19(1):52-8. PubMed ID: 26750674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study.
    Tritapepe L; De Santis V; Vitale D; Santulli M; Morelli A; Nofroni I; Puddu PE; Singer M; Pietropaoli P
    Br J Anaesth; 2006 Jun; 96(6):694-700. PubMed ID: 16595616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study.
    Shah B; Sharma P; Brahmbhatt A; Shah R; Rathod B; Shastri N; Patel J; Malhotra A
    Indian J Pharmacol; 2014; 46(1):29-34. PubMed ID: 24550581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
    N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Eriksson HI; Jalonen JR; Heikkinen LO; Kivikko M; Laine M; Leino KA; Kuitunen AH; Kuttila KT; Peräkylä TK; Sarapohja T; Suojaranta-Ylinen RT; Valtonen M; Salmenperä MT
    Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.].
    Pasyuga VV; Belov SI; Yusupova ES; Adzhigaliev RR; Berezhnoy SA; Panov OS; Tarasov DG; Yavorovsky AG
    Anesteziol Reanimatol; 2016 Sep; 61(5):334-338. PubMed ID: 29489098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
    Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study.
    Desai PM; Sarkar MS; Umbarkar SR
    Ann Card Anaesth; 2018; 21(2):123-128. PubMed ID: 29652271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
    Atalay H; Temizturk Z; Altinsoy HB; Azboy D; Colak S; Atalay A; Dogan OF
    Heart Surg Forum; 2016 Oct; 19(5):E230-E236. PubMed ID: 27801303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
    Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
    Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
    Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
    Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
    Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
    Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.
    Lilleberg J; Nieminen MS; Akkila J; Heikkilä L; Kuitunen A; Lehtonen L; Verkkala K; Mattila S; Salmenperä M
    Eur Heart J; 1998 Apr; 19(4):660-8. PubMed ID: 9597417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.